Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Advanced Solid Tumor, Adult × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 606 Breast Neoplasms 540 Neoplasms 502 Leukemia, Myeloid, Acute 413 Colorectal Neoplasms 382 Multiple Myeloma 372 Melanoma 360 Prostatic Neoplasms 324 Neoplasm Metastasis 314 Pancreatic Neoplasms 311 Lymphoma 291 Recurrence 281 Ovarian Neoplasms 280 Lung Neoplasms 257 Leukemia 253 Lymphoma, Non-Hodgkin 247 Glioblastoma 240 Precursor Cell Lymphoblastic Leukemia-Lymphoma 215 Stomach Neoplasms 211 Leukemia, Lymphocytic, Chronic, B-Cell 200 Carcinoma, Hepatocellular 197 Squamous Cell Carcinoma of Head and Neck 183 Myelodysplastic Syndromes 183 Lymphoma, Large B-Cell, Diffuse 180 Carcinoma, Renal Cell 175 Brain Neoplasms 155 Lymphoma, Follicular 148 Head and Neck Neoplasms 142 Triple Negative Breast Neoplasms 139 Lymphoma, Mantle-Cell 136

Interventions

olaparib 1 niraparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04972110 2025-10-30

ATTACC

Repare Therapeutics

Phase 1/2 Terminated

156 enrolled 19 charts

Other solid neoplasm

Advanced Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon ⚡